Prescribing information

 

Prescribing information

Welcome to the Severe Asthma on-demand webinars page. Here you can access videos from webinars in the field of severe asthma, including those from the Masterclass series and the Empower Patients series.

 

 

Meeting date: 21st June 2021
HOW SIGNIFICANT IS ALLERGY IN PAEDIATRIC ASTHMA?

Speaking at the 2021 Severe Asthma Masterclass, Dr Katy Pike discusses the significance of allergy in paediatric asthma, whether it plays a role in causing or worsening of asthma, what this means for patients and whether treatment strategies should recognise allergens.
 

 

 

 

Meeting date: 21st June 2021
HOW DO WE BEST TACKLE PAEDIATRIC SEVERE ASTHMA?

Speaking at the 2021 Severe Asthma Masterclass, Professor Prassad Nagakumar discusses the use of biologics for the treatment of paediatric patients with severe asthma, focusing on those with approval and those in the pipeline. He pays particular attention to the challenges treating clinicians face with biologics, examining the importance of potential prediction of response, as well as monitoring.
 

 

 

 

Meeting date: 21st June 2021
SOCIOECONOMIC DRIVERS OF ASTHMA IN CHILDREN

Speaking at the 2021 Severe Asthma Masterclass, Professor Ian Sinha talks about one of the biggest challenges paediatricians face in childhood asthma and how poor socioeconomic conditions affect outcomes of children with asthma. He also discusses the importance of quality of care and what can be done to improve the outcomes of these children.
 

 

 
 

 

Meeting date: 14th June 2021
ASTHMA AND PREGNANCY NOW AND IN THE FUTURE

Speaking at the 2021 Severe Asthma Masterclass, Dr Sarah Winfield discusses the significance of pregnancy to asthmatic patients, including what changes occur during pregnancy that affect respiratory functioning, how asthma is managed optimally during labour and breastfeeding, and how omalizumab can be used in this subset of patients.
 

 

 

 

Meeting date: 14th June 2021
MANAGING COMPLEX CASES

Speaking at the 2021 Severe Asthma Masterclass, Professor Adel Mansur presents case studies to demonstrate the use of corticosteroids, both as rescue therapy and at lower doses for maintenance, and the challenges associated with switching to biologics.
 

 

 

 

Meeting date: 14th June 2021
HOW HAS DIGITAL TECHNOLOGY EVOLVED TO SUPPORT ASTHMA MANAGEMENT?

Speaking at the 2021 Severe Asthma Masterclass, Professor Liam Heaney looks at the evolution of digital technology and its influence on asthma management, particularly since the COVID-19 pandemic. He discusses what has worked well and how it has successfully impacted clinical practice.
 

 

 
 

 

Meeting date: 22nd March 2021
THE RIGHT BIOLOGIC FOR THE RIGHT PATIENT

Dr Hitasha Rupani explores decision making in severe asthma, including criteria for biologic choice, factors predicting good response, and efforts to reduce reliance on oral steroids.
 

 

 

 

Meeting date: 22nd March 2021
NASAL POLYPS – WHAT ASTHMA DOCTORS NEED TO KNOW?

Dr Glenis Scadding discusses the symptoms, diagnosis and treatment of nasal polyps, with a focus on the link to asthma, and what future treatments could look like.

 

 

 

Meeting date: 22nd March 2021
CORTICOSTEROIDS IN ASTHMA – AN ENDOCRINOLOGIST’S VIEW

Prof. Mark Gurnell examines the aetiology and clinical features of adrenal insufficiency, reasons for increased prevalence, and steroid sick day rules to keep patients safe.

 

 
 

 

COVID-19 AND SEVERE ASTHMA

In this 2020 webinar, Prof. Andrew Menzies-Gow discusses the lessons learned from the COVID-19 pandemic and how we can use these to improve severe asthma services in the future. This is followed by an expert panel discussion chaired by Dr Rob Niven and including Prof. Andrew Menzies-Gow, Rachel Stead and Dr Helen Hope.
 

 

 
 

 

ALLERGIC ASTHMA – DO WE GET IT RIGHT?

Speaking at the 2019 Severe Asthma Masterclass, Dr Robin Gore discusses recent progress in severe allergic asthma, our current understanding of the disease, and the importance of having the right tools to evaluate patients.
 

 

 

 

REFLUX AND ASTHMA – WHAT IS THE RELATIONSHIP?

Speaking at the 2019 Severe Asthma Masterclass, Prof. Alyn Morice discusses the relationship between oesophageal diseases, such as cough hypersensitivity syndrome, and the treatment of asthma.
 

 

 

 

ALLERGEN AVOIDANCE – ARE WE GETTING IT RIGHT?

Speaking at the 2019 Paediatric Severe Asthma Masterclass, Dr Clare Murray discusses the role of allergen exposure in children with asthma, and whether avoidance strategies can be used to improve asthma control.
 

 

 
 

 

RIGHT MEDICINE, RIGHT CARE SETTING

Anusha Patel discusses homecare in severe asthma, finding suitable patients and securing NHS funding to add omalizumab to homecare services in the East Midlands.
 

 

 

 

BIOLOGIC CHOICE AND SHARED DECISION-MAKING

Dr James Calvert looks at evidence-based decision-making to compare quality of services and improve the value consensus in the choice of biologics within the NHS.
 

 

 

 

EMPOWERING PATIENT CHOICE

Nurse Sally Butters leads a discussion with a patient to gain insights into their experience with severe asthma and treatment journey with Xolair® (omalizumab).
 

 

Prescribing information for Xolair® (omalizumab) and adverse event reporting details can be found here

Rate this content: 
No votes yet
UK | October 2021 | 156538
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]